Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease
(MedPage Today) -- BARCELONA -- Rheumatoid arthritis patients with existing interstitial lung disease (ILD) had less decline in lung function when receiving the antifibrotic agent pirfenidone (Esbriet) relative to placebo in a randomized trial... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 6, 2022 Category: Rheumatology Source Type: news
One Young Mom's Journey With Rheumatoid Arthritis
TUESDAY, Sept. 6, 2022 -- Nearly 10 years ago, Tania Morales was a busy working mom when she was suddenly struck by pain, joint stiffness and exhaustion.“I felt alarmed, where it got to a point where I was telling my husband,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 6, 2022 Category: General Medicine Source Type: news
Study Reassures on HCQ Heart Risks in Rheumatoid Arthritis
(MedPage Today) -- Among U.S. veterans receiving hydroxychloroquine (HCQ) as long-term therapy for rheumatoid arthritis, development of long QT syndrome was rare and not markedly more common compared with similar patients treated with other agents... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 2, 2022 Category: Rheumatology Source Type: news
AI Model Can Quantify Radiographic Joint Damage in RA
FRIDAY, Sept. 2, 2022 -- An international competition resulted in the development of algorithms that provide feasible, quick, and accurate methods to quantify joint damage in rheumatoid arthritis (RA), according to a study published online Aug. 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 2, 2022 Category: Pharmaceuticals Source Type: news
Lupus, MS and Other Autoimmune Disorders Raise Heart Risks
WEDNESDAY, Aug. 31, 2022 -- Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 31, 2022 Category: General Medicine Source Type: news
Olokizumab Tops Placebo for RA Patients Receiving Methotrexate
THURSDAY, Aug. 25, 2022 -- Olokizumab is superior to placebo and noninferior to adalimumab in patients with rheumatoid arthritis receiving maintenance methotrexate, according to a study published in the Aug. 25 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 25, 2022 Category: Pharmaceuticals Source Type: news
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis
(MedPage Today) -- A new type of anti-interleukin-6 (IL-6) biologic called olokizumab was as effective as adalimumab (Humira) in rheumatoid arthritis patients who needed a step up from methotrexate monotherapy, results from a phase III trial indicated... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - August 25, 2022 Category: Rheumatology Source Type: news
Role of Genetics Studied in Rheumatoid Arthritis Development
TUESDAY, Aug. 16, 2022 -- Genetic predisposition is increased across patients with pre-rheumatoid arthritis (RA), according to a study published online Aug. 12 in Arthritis& Rheumatology.
Marc P. Maurits, from the Leiden University Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 16, 2022 Category: Pharmaceuticals Source Type: news
App Aids Self-Monitoring of Some Rheumatoid Arthritis Patients
FRIDAY, Aug. 12, 2022 -- Patient-initiated care supported with smartphone self-monitoring is noninferior to usual care for rheumatoid arthritis (RA) in patients with stable low disease activity, according to a study published online July 11 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2022 Category: Pharmaceuticals Source Type: news
In RA, Tofacitinib Has Higher Infection Rate Than TNFi In RA, Tofacitinib Has Higher Infection Rate Than TNFi
Patients with rheumatoid arthritis are at greater risk for infection if they ' re treated with tofacitinib than with a tumor necrosis factor inhibitor (TNFi), according to an industry-funded study.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 11, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news
From the archive: Are western lifestyles causing a rise in autoimmune diseases? | podcast
Could the food we eat and the air we breathe be damaging our immune systems? The number of people with autoimmune diseases, from rheumatoid arthritis to type 1 diabetes, began to increase around 40 years ago in the west. Now, some are also emerging in countries that had never seen the diseases before.In this episode from January 2022, Ian Sample speaks to the genetic scientist and consultant gastroenterologist James Lee about how this points to what western lifestyles might be doing to our health, and how genetics could reveal exactly how our immune systems are malfunctioningArchive: King 5 News, WXYZ Channel 7Continue rea...
Source: Guardian Unlimited Science - August 11, 2022 Category: Science Authors: Presented by Ian Sample, produced by Madeleine Finlay, sound design by Axel Kacouti é, and the executive producer was Max Sanderson Tags: Science Biology Genetics Source Type: news
More Bad Safety News for Xeljanz
(MedPage Today) -- Another analysis of the mandatory postmarketing safety study for tofacitinib (Xeljanz) has confirmed what most observers expected: that rates of infection with the drug in rheumatoid arthritis are higher than with tumor necrosis... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 4, 2022 Category: Primary Care Source Type: news
7 Potential Complications of Untreated Rheumatoid Arthritis (RA)
Title: 7 Potential Complications of Untreated Rheumatoid Arthritis (RA)Category: Health FactsCreated: 1/24/2012 12:00:00 AMLast Editorial Review: 8/4/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 4, 2022 Category: Rheumatology Source Type: news
TNF Inhibitor Use for RA Shows Beneficial Effect in Pregnancy TNF Inhibitor Use for RA Shows Beneficial Effect in Pregnancy
Women who treated their rheumatoid arthritis during pregnancy with a tumor necrosis factor inhibitor gave birth to infants with higher birth weights, without a higher risk of adverse outcomes.Medscape Medical News (Source: Medscape Nurses Headlines)
Source: Medscape Nurses Headlines - July 28, 2022 Category: Nursing Tags: Rheumatology News Source Type: news
Short Sleep Duration Causally Linked to Rheumatoid Arthritis
THURSDAY, July 21, 2022 -- Short sleep duration is causally associated with an increased risk for rheumatoid arthritis (RA), according to a study published online June 30 in Frontiers in Public Health.
Rui-Chen Gao, from the School of Nursing at... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2022 Category: Pharmaceuticals Source Type: news
